Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion type Assertion NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_head.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion evidence source_evidence_curated NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion SIO_000772 21535412 NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion wasDerivedFrom ctd_human-20130708 NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.
- NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion wasGeneratedBy ECO_0000218 NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.